Medical Journals In Histology
Histological studies have been used to investigate the biological processes at work in the skin in chronic venous disease. A quantitative histological study has been reported in which three groups of patients was studied. The first was a group of patients with no evidence of skin changes as a consequence of their venous disease. The next group exhibited lipodermatosclerosis without a
history of ulceration. The third group had healed ulcers with residual lipodermatosclerosis. Patients with normal skin had a low number of white blood
cells visible (4 per mm2) in the upper 0.5 mm of the skin. There were eight times as many in patients with lip sclerotic skin, and 40 times as many in patients with healed venous ulcers. Subsequently an immunohistological study was undertaken to determine the types of white cell present in this infiltrate. The majority of
cells are macrophages with a T-lymphocyte component, but no excess of neutrophils compared with control sections taken from normal limbs. So this infiltrate is a reflection of a chronic inflammatory process. Histology remains the strongest predictor of outcome. In particular, anaplasia, defined by
cells showing irregular mitosis, enlarged nuclei, and hyperchromasia, portends a poorer outcome compared with favorable-histology (standard triphasic) tumors. Anaplasia is subdivided further into diffuse or focal categories.
High Impact List of Articles
-
Market growth of Nursing Care Research in the last and upcoming ten years
Susan E. Mazer
Editorial: Clinical Investigation
-
Market growth of Nursing Care Research in the last and upcoming ten years
Susan E. Mazer
Editorial: Clinical Investigation
-
Market growth of Nursing Care Research in the last and upcoming ten years
Susan E. Mazer
Editorial: Clinical Investigation
-
Market growth of Nursing Care Research in the last and upcoming ten years
Susan E. Mazer
Editorial: Clinical Investigation
-
Market growth of Nursing Care Research in the last and upcoming ten years
Susan E. Mazer
Editorial: Clinical Investigation
-
Market growth of Nursing Care Research in the last and upcoming ten years
Susan E. Mazer
Editorial: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Advances in the treatment of heparin-induced thrombocytopenia: latest clinical data
Gregor Hron, Andreas Greinacher
Review Article: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
-
Assessing clinical efficacy of drugs in cancer patients: are we on the right track?
Ciro Gallo, Francesco Perrone
Editorial: Clinical Investigation
Relevant Topics in Clinical